AW

Anisha W.

Vice President Regulatory Affairs at AVEO Oncology

Anisha W. has extensive experience in regulatory affairs, specifically in the field of oncology. Anisha is currently employed as the Vice President of Regulatory Affairs at AVEO Oncology since August 2022. Prior to this role, they worked as the Senior Director of Regulatory Affairs at AVEO Oncology from April 2021 to August 2022.

Before joining AVEO Oncology, Anisha worked at Merck as the Director of Global Regulatory Affairs - Oncology from January 2017 to March 2021.

Anisha also has experience at Nektar Therapeutics, where they held the position of Associate Director of Regulatory Affairs (Oncology) from February 2013 to January 2017, and before that, as the Manager of Regulatory Affairs (Oncology) from November 2011 to February 2013.

Anisha gained valuable experience at InterMune, where they worked as the Manager of Regulatory Affairs (Pulmonology) from June 2009 to November 2011.

Additionally, they worked at InSite Vision, Inc. as the Senior Specialist of Regulatory Affairs (Ophthalmology) from August 2006 to April 2009.

Anisha's career began at Genentech, where they worked as a Regulatory Affairs Analyst (Regulatory Intelligence) from August 2004 to August 2006.

Overall, Anisha W. has a strong background in regulatory affairs, particularly in the oncology field, and has held various positions of increasing responsibility throughout their career.

Anisha W. attended Clark Atlanta University and obtained a Bachelor of Science degree in Biology/Biological Sciences, with a focus on General Studies. Anisha then pursued further education at the University of Minnesota, where they studied Epidemiology. Finally, Anisha completed their educational journey at the University of San Francisco, where they earned a Master of Business Administration (Executive MBA Program) degree, specializing in Business Administration and Management. The exact dates for each educational experience are not provided.

Links

Timeline

  • Vice President Regulatory Affairs

    August, 2022 - present

  • Sr Director Regulatory Affairs

    April, 2021

View in org chart